HIKO STEC Study
Hydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E.Coli Infection: A Multinational Imbedded Cluster Crossover Randomized Trial
- Sex: Any
- Age: Child (Birth - 17), Adult (18 - 64)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase III
- Conditions Being Studied: Shiga Toxin-Producing Escherichia Coli (STEC) Infection
Study Purpose
The purpose of this study is to determine if early high volume intravenous fluid administration (hyperhydration) to children diagnosed with STEC infection improves kidney and other clinical outcomes when compared with a conservative fluid management approach.
Who Can Participate
Participants 9 months to < 21 years old with a diagnosis of STEC infection or early HUS may be eligible for this study.
Locations
UH Rainbow Babies & Children's
2101 Adelbert Rd
Cleveland OH, 44106
- UH IRB: SITE00001627
- StudyID: 2022-0980
- ClinicalTrials.gov: NCT05219110
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422